Literature DB >> 26286731

The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene.

Michael M Gottesman1, Ira H Pastan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26286731      PMCID： PMC4836801          DOI： 10.1093/jnci/djv222

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  26 in total

Review 1.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

2.  Measurement of multidrug-resistance messenger RNA in urogenital cancers; elevated expression in renal cell carcinoma is associated with intrinsic drug resistance.

Authors:  Y Kakehi; H Kanamaru; O Yoshida; H Ohkubo; S Nakanishi; M M Gottesman; I Pastan
Journal:  J Urol       Date:  1988-04       Impact factor: 7.450

3.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

4.  Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

Authors:  Gergely Szakács; Jean-Philippe Annereau; Samir Lababidi; Uma Shankavaram; Angela Arciello; Kimberly J Bussey; William Reinhold; Yanping Guo; Gary D Kruh; Mark Reimers; John N Weinstein; Michael M Gottesman
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

5.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Authors:  R F Ozols; R E Cunnion; R W Klecker; T C Hamilton; Y Ostchega; J E Parrillo; R C Young
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

6.  MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants.

Authors:  H Kanamaru; Y Kakehi; O Yoshida; S Nakanishi; I Pastan; M M Gottesman
Journal:  J Natl Cancer Inst       Date:  1989-06-07       Impact factor: 13.506

7.  Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

Authors:  A Fojo; S Akiyama; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

8.  Expression of a human multidrug resistance gene in ovarian carcinomas.

Authors:  J Bourhis; L J Goldstein; G Riou; I Pastan; M M Gottesman; J Bénard
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

9.  Expression of the multidrug resistance gene in myeloid leukemias.

Authors:  H Sato; M M Gottesman; L J Goldstein; I Pastan; A M Block; A A Sandberg; H D Preisler
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

10.  MDR1 gene expression in lung cancer.

Authors:  S L Lai; L J Goldstein; M M Gottesman; I Pastan; C M Tsai; B E Johnson; J L Mulshine; D C Ihde; K Kayser; A F Gazdar
Journal:  J Natl Cancer Inst       Date:  1989-08-02       Impact factor: 13.506
View more
  39 in total

1.  Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation.

Authors:  Imane El Meouche; Mary J Dunlop
Journal:  Science       Date:  2018-11-09       Impact factor: 47.728

Review 2.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

3.  Optimizing Targeted Inhibitors of P-Glycoprotein Using Computational and Structure-Guided Approaches.

Authors:  John G Wise; Amila K Nanayakkara; Maha Aljowni; Gang Chen; Maisa C De Oliveira; Lauren Ammerman; Ketetha Olengue; Alexander R Lippert; Pia D Vogel
Journal:  J Med Chem       Date:  2019-11-26       Impact factor: 7.446

4.  Anti-ABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway.

Authors:  Wen-Si Zhao; Yi Luo; Bo-Yi Li; Han-Jing Zhou; Tao Zhang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 5.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

6.  SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway.

Authors:  Haitao Guan; Ping Zhao; Zhijun Dai; Xiaoxu Liu; Xijing Wang
Journal:  Tumour Biol       Date:  2016-05-24

7.  P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.

Authors:  Chengqiong Mao; Ping Qu; Michael J Miley; Yan Zhao; Zibo Li; Xin Ming
Journal:  Biomater Sci       Date:  2018-10-24       Impact factor: 6.843

8.  The effects of anthracycline drugs on the conformational distribution of mouse P-glycoprotein explains their transport rate differences.

Authors:  P H Nguyen; K P Sigdel; K G Schaefer; G A K Mensah; G M King; A G Roberts
Journal:  Biochem Pharmacol       Date:  2020-01-16       Impact factor: 5.858

Review 9.  Piperine: role in prevention and progression of cancer.

Authors:  Mariia Zadorozhna; Tiziana Tataranni; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

10.  Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.

Authors:  Birandra K Sinha; Lalith Perera; Ronald E Cannon
Journal:  Biomed Pharmacother       Date:  2019-10-09       Impact factor: 6.529
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.